Novel end points for clinical trials in young children with cystic fibrosis

Author： Simpson Shannon J   Mott Lauren S   Esther Jr Charles R   Stick Stephen M   Hall Graham L  

Publisher： Informa Healthcare

ISSN： 1747-6348

Source： Expert Review of Respiratory Medicine, Vol.7, Iss.3, 2013-06, pp. : 231-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?

By Legro Richard S.   for the Reproductive Medicine Network  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1697-1704

Oxford University Press

Access to resources Recommend Favorite

CASE REPORT: Clostridium difficile Colitis in Children with Cystic Fibrosis

By Hussain Sunny Zaheed   Chu Cathy   Greenberg David P.   Orenstein David   Khan Seema  

Digestive Diseases and Sciences, Vol. 49, Iss. 1, 2004-01 ,pp. : 116-121

Springer Publishing Company

Access to resources Recommend Favorite

Improved Outcomes of Patients with End-stage Cystic Fibrosis Requiring Invasive Mechanical Ventilation for Acute Respiratory Failure

By Hayes Don  

Lung, Vol. 189, Iss. 5, 2011-10 ,pp. : 409-415

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?

By Bruyere Olivier   Reginster Jean-Yves  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 199-206

Future Medicine

Access to resources Recommend Favorite

Macrolides in Cystic Fibrosis: Is There a Role?

By Wolter J.M.   Seeney S.L.   McCormack J.G.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 4, 2002-04 ,pp. : 235-241

Adis International

Access to resources Recommend Favorite